We are live on ! Find out more
UPC icon

Universe Pharmaceuticals Inc
UPC

2 hedge funds and large institutions have $5.81K invested in Universe Pharmaceuticals Inc in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% less ownership

Funds ownership: 0.45% → 0.2% (-0.25%)

50% less funds holding

Funds holding: 4 → 2 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

83% less capital invested

Capital invested by funds: $33.7K → $5.81K (-$27.8K)

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.01K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$9K
2
TSS
Two Sigma Securities
New York
-$6.65K
3
HF
HRT Financial
New York
-$6K

UPC Hedge Fund Activity: Q3 2023 in Review

2 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q3 2023, worth a combined $5.81K — down 83% from $33.7K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of UPC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was UBS Group, opening a new position worth an estimated $1.01K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $9K sold.

  • 2 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q3 2023, down from 4 in Q2 2023.
  • Funds reported $5.81K of Universe Pharmaceuticals Inc stock for Q3 2023, down 83% quarter-over-quarter.
  • 1 fund opened new Universe Pharmaceuticals Inc positions in Q3 2023 and 3 closed out, a net change of -2 holders.
  • The largest Universe Pharmaceuticals Inc buyer in Q3 2023 was UBS Group, an estimated $1.01K added.
  • The largest Universe Pharmaceuticals Inc seller in Q3 2023 was Renaissance Technologies, an estimated $9K sold.

Based on aggregated 13F filings for Q3 2023.